相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics
Anna S. Nam et al.
NATURE REVIEWS GENETICS (2021)
Downregulation of N-myc Interactor Promotes Cervical Cancer Cells Growth by Activating Stat3 Signaling
Songbin Wu et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2021)
ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma
Tianbo Xu et al.
AGING-US (2020)
All About the RNA: Interferon-Stimulated Genes That Interfere With Viral RNA Processes
Emily Yang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Downregulation of N-myc and STAT Interactor Protein Predicts Aggressive Tumor Behavior and Poor Prognosis in Invasive Ductal Carcinoma
Ji Eun Choi et al.
JOURNAL OF BREAST CANCER (2020)
ISG20 promotes local tumor immunity and contributes to poor survival in human glioma
Mengqi Gao et al.
ONCOIMMUNOLOGY (2019)
Conditional knockout of N-Myc and STAT interactor disrupts normal mammary development and enhances metastatic ability of mammary tumors
Hawley C. Pruitt et al.
ONCOGENE (2018)
Stimulation of Interferon-Stimulated Gene 20 by Thyroid Hormone Enhances Angiogenesis in Liver Cancer
Syuan-Ling Lin et al.
NEOPLASIA (2018)
miRWalk: An online resource for prediction of microRNA binding sites
Carsten Sticht et al.
PLOS ONE (2018)
Oestrogen receptor α AF-1 and AF-2 domains have cell population-specific functions in the mammary epithelium
Stephanie Cagnet et al.
NATURE COMMUNICATIONS (2018)
Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas
Jingshu Wang et al.
MOLECULAR CANCER (2017)
NMI inhibits cancer stem cell traits by downregulating hTERT in breast cancer
Xu Feng et al.
CELL DEATH & DISEASE (2017)
NMI and IFP35 serve as proinflammatory DAMPs during cellular infection and injury
Zhikai Xiahou et al.
NATURE COMMUNICATIONS (2017)
Differentiation dynamics of mammary epithelial cells revealed by single-cell RNA sequencing
Karsten Bach et al.
NATURE COMMUNICATIONS (2017)
Interferon-stimulated gene 20-kDa protein (ISG20) in infection and disease: Review and outlook
Zhiwei Zheng et al.
INTRACTABLE & RARE DISEASES RESEARCH (2017)
Developing Cures: Targeting Ontogenesis in Cancer
Victor T. G. Lin et al.
TRENDS IN CANCER (2017)
Roles of N-Myc and STAT Interactor in Cancer: From Initiation to Dissemination
Hawley C. Pruitt et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Hierarchy within the mammary STAT5-driven Wap super-enhancer
Ha Youn Shin et al.
NATURE GENETICS (2016)
Mammary gland development: cell fate specification, stem cells and the microenvironment
Jamie L. Inman et al.
DEVELOPMENT (2015)
Signal Transduction in Cancer
Richard Sever et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
Tuan Zea Tan et al.
EMBO MOLECULAR MEDICINE (2014)
STAT signaling in mammary gland differentiation, cell survival and tumorigenesis
S. Haricharan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
In situ identification of bipotent stem cells in the mammary gland
Anne C. Rios et al.
NATURE (2014)
Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-β/SMAD signaling
D. J. Devine et al.
ONCOGENE (2014)
Sequential activation of genetic programs in mouse mammary epithelium during pregnancy depends on STAT5A/B concentration
Daisuke Yamaji et al.
NUCLEIC ACIDS RESEARCH (2013)
The MicroRNA-17-92 Family of MicroRNA Clusters in Development and Disease
Carla P. Concepcion et al.
CANCER JOURNAL (2012)
The miR-17/92 cluster is targeted by STAT5 but dispensable for mammary development
Yonatan Feuermann et al.
GENESIS (2012)
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes
Amy R. Peck et al.
BREAST CANCER RESEARCH (2012)
Loss of Nuclear Localized and Tyrosine Phosphorylated Stat5 in Breast Cancer Predicts Poor Clinical Outcome and Increased Risk of Antiestrogen Therapy Failure
Amy R. Peck et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Antiviral activities of ISG20 in positive-strand RNA virus infections
Zhi Zhou et al.
VIROLOGY (2011)
Modeling metastasis biology and therapy in real time in the mouse lung
Arnulfo Mendoza et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A
Daisuke Yamaji et al.
GENES & DEVELOPMENT (2009)
Mammary development in the embryo and adult: a journey of morphogenesis and commitment
Christine J. Watson et al.
DEVELOPMENT (2008)
Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression
Kay-Uwe Wagner et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERα-negative and ERα-positive mammary preneoplasia and cancer
L. P. Jones et al.
ONCOGENE (2008)
The epithelial-mesenchymal transition: new insights in signaling, development, and disease
JM Lee et al.
JOURNAL OF CELL BIOLOGY (2006)
Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells
Z Nouhi et al.
CANCER RESEARCH (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells
AS Sultan et al.
ONCOGENE (2005)
Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation
Y Cui et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Signal transducer and activator of transcription-5 activation and breast cancer prognosis
MT Nevalainen et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
分享论文
